UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042342
Receipt number R000048339
Scientific Title Blood metabolome profiling for phenotyping severe asthma in Japan
Date of disclosure of the study information 2020/11/05
Last modified on 2022/04/06 10:15:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Blood metabolome profiling for phenotyping severe asthma in Japan

Acronym

NHOM-metabolomics

Scientific Title

Blood metabolome profiling for phenotyping severe asthma in Japan

Scientific Title:Acronym

NHOM-metabolomics

Region

Japan


Condition

Condition

Asthma

Classification by specialty

Medicine in general Pneumology Clinical immunology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to identify metabolome profile among severe asthma in Japan.

Basic objectives2

Others

Basic objectives -Others

The aim of this study is to identify metabolome profile among severe asthma in Japan.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Metabolome profiling among severe asthma phenotypes

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Asthma
(1) severe asthma
(2) patient visiting participating hospitals
(3) patient with informed consent
(4) age above 16
Healthy Control
(1) age above 16
(2) subject with informed consent
(3) subject without any disease

Key exclusion criteria

subject whom the investigator thinks not appropriate for participation in this study

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Maho
Middle name
Last name Suzukawa

Organization

National Hospital Organization Tokyo National Hospital

Division name

Clinical Research Center

Zip code

204-8585

Address

3-1-1 Takeoka

TEL

042-491-2111

Email

fueta-tky@umin.ac.jp


Public contact

Name of contact person

1st name Maho
Middle name
Last name Suzukawa

Organization

National Hospital Organization Tokyo National Hospital

Division name

Clinical Research Center

Zip code

204-8585

Address

3-1-1 Takeoka

TEL

042-491-2111

Homepage URL


Email

fueta-tky@umin.ac.jp


Sponsor or person

Institute

National Hospital Organization Tokyo National Hospital

Institute

Department

Personal name



Funding Source

Organization

National Hospital Organization

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Hospital Organization IRB

Address

2-5-21 Higashigaoka, Meguro-Ku, Tokyo

Tel

03-5712-5050

Email

700-kenkyu@mail.hosp.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 11 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2020 Year 08 Month 27 Day

Date of IRB

2020 Year 08 Month 27 Day

Anticipated trial start date

2021 Year 01 Month 01 Day

Last follow-up date

2021 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Observational study


Management information

Registered date

2020 Year 11 Month 04 Day

Last modified on

2022 Year 04 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048339


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name